Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; to Supply One Billion Vaccines Medical Dialogues Bureau31 March 2020 7:36 AM GMTNew Brunswick: Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since...
Thermo Fisher Scientific collaborates with Janssen to Develop Companion Diagnostic for Cancer Medical Dialogues Bureau13 March 2020 4:00 AM GMTOncomine Dx Target Test is a next-generation sequencing (NGS) assay that contains 46 cancer-related biomarkers and a workflow that features a fast...
New tests shows NO sign of asbestos in recalled JnJ baby powder Medical Dialogues Bureau30 Oct 2019 7:48 AM GMTBut Johnson & Johnson (JnJ) said in a statement that dozens of tests by two outside firms did not detect any asbestos in JnJ's baby powder.New...
Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda Medical Dialogues Bureau9 Oct 2019 10:54 AM GMTJohnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...
JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030 Medical Dialogues Bureau7 Oct 2019 4:00 AM GMTNEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
Novartis, Lonza strengthen biosimilars push with MS, arthritis drug deals Medical Dialogues Bureau3 Sep 2019 4:00 AM GMTNovartis's Sandoz generics unit, among the biggest biosimilars makers, on Tuesday, agreed to license from Poland's Polpharma Biologics a version of...
Oklahoma judge to rule in opioid lawsuit against JnJ Medical Dialogues Bureau24 Aug 2019 3:40 AM GMTLawyers for the state called JnJ an opioid "kingpin" and contended its marketing efforts created a public nuisance in the form of the opioid crisis as...
Canada enacts drug price crackdown, in blow to pharmaceutical industry Medical Dialogues Bureau11 Aug 2019 3:30 AM GMTThe changes are the biggest reform to Canada's drug price regime since 1987 and could eventually cut the earnings of drugmakers in the United States,...
Oklahoma judge denies motion to end case against drugmaker JnJ Medical Dialogues Bureau9 July 2019 3:30 AM GMTDistrict Judge Thad Balkman denied Johnson & Johnson lawyers' motion asking him to end the case mid-trial and rule in favour of the New Brunswick,...
Oklahoma judge approves Teva Pharma USD 85 million opioid settlement Medical Dialogues Bureau25 Jun 2019 3:30 AM GMTU.S: An Oklahoma judge on Monday approved a revised $85 million settlement with Teva Pharmaceutical Industries Ltd (Teva Pharma) resolving claims by...
Swiss company Actelion moves US court against Natco Pharma over generic of its patented drug Medical Dialogues Bureau5 Jun 2019 6:57 AM GMTHyderabad: Swiss pharma company Actelion Pharmaceuticals Ltd has filed a petition in a US court alleging that Natco Pharma and its US partner Syneos...
Teva Pharma to settle $85 million opioid claims of Oklahoma Medical Dialogues Bureau27 May 2019 3:30 AM GMTOklahoma Attorney General Mike Hunter has alleged that JnJ and Teva Pharma, along with OxyContin maker Purdue Pharma LP, carried out deceptive marking...